Last update 01 Nov 2024
Guangzhou Shunjian Biomedical Technology Co., Ltd.
Private Company|
2012|
Guangdong Sheng, China
Last update 01 Nov 2024
Overview
Tags
Neoplasms
Digestive System Disorders
Hemic and Lymphatic Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
奥雷巴替尼联合化疗对比伊马替尼联合化疗治疗新诊断Ph染色体阳性的急性淋巴细胞白血病（Ph+ALL）患者的关键注册性III期临床研究
[Translation] A pivotal registration phase III study of ogrebatinib plus chemotherapy versus imatinib plus chemotherapy in patients with newly diagnosed Ph+ ALL
APG-5918治疗贫血的安全性、药代动力学和有效性的Ⅰ期临床研究
[Translation] Phase I clinical study on the safety, pharmacokinetics and efficacy of APG-5918 in the treatment of anemia
一项在晚期实体瘤或血液系统恶性肿瘤患者中评价口服APG-5918的安全性、药代动力学和疗效的I 期研究
[Translation] A Phase I Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Oral APG-5918 in Patients with Advanced Solid Tumors or Hematologic Malignancies
100 Clinical Results associated with Guangzhou Shunjian Biomedical Technology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Guangzhou Shunjian Biomedical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Guangzhou Shunjian Biomedical Technology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 22 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
1
Approved
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free